Invokana (canagliflozin) is a medicine used alongside diet and exercise to lower blood sugar with type 2 diabetes. It also reduces risks of heart attack, stroke, and cardiovascular death in these patients. Furthermore, it is used to lower the risk of end-stage kidney disease and hospitalization for heart failure in adults with diabetic kidney disease.
